Table 1

Characteristics and outcome of MDS patients treated with AZA according to IPSS-R parameters

VariablePercentageResponse according to IWG 20064POS, moP
Hemoglobin, g/dL      
 <8 18% 44% .948 8.1 .06 
 8-10 48% 42%  15.3  
 >10 34% 44%  14.1  
Absolute neutrophil count, ×109/L      
 <0.8 45% 45% .465 15.3 .4 
 >0.8 54% 40%  12.2  
Platelet count, ×109/L      
 <50 43% 40% .10 9.7 .0001 
 50-100 32% 42%  15.1  
 >100 25% 50%  20.3  
BM blasts, %      
 ≤2 2% 60% .287 16.1 .12 
 3-5 3% 70%  8.1  
 5-10 18% 44%  15.9  
 >10 77% 41%  14.1  
Cytogenetic group      
 Very good 1%  .646  .0001 
 Good 37% 46%  21.8  
 Intermediate 18% 39%  12.3  
 Poor 12% 45%  15.1  
 Very poor 32% 38%  7.1  
IPSS-R classification      
 Low <1%  .463  .0001 
 Intermediate 11% 46%  30.7  
 High 34% 47%  17.6  
 Very high 55% 39%  10  
VariablePercentageResponse according to IWG 20064POS, moP
Hemoglobin, g/dL      
 <8 18% 44% .948 8.1 .06 
 8-10 48% 42%  15.3  
 >10 34% 44%  14.1  
Absolute neutrophil count, ×109/L      
 <0.8 45% 45% .465 15.3 .4 
 >0.8 54% 40%  12.2  
Platelet count, ×109/L      
 <50 43% 40% .10 9.7 .0001 
 50-100 32% 42%  15.1  
 >100 25% 50%  20.3  
BM blasts, %      
 ≤2 2% 60% .287 16.1 .12 
 3-5 3% 70%  8.1  
 5-10 18% 44%  15.9  
 >10 77% 41%  14.1  
Cytogenetic group      
 Very good 1%  .646  .0001 
 Good 37% 46%  21.8  
 Intermediate 18% 39%  12.3  
 Poor 12% 45%  15.1  
 Very poor 32% 38%  7.1  
IPSS-R classification      
 Low <1%  .463  .0001 
 Intermediate 11% 46%  30.7  
 High 34% 47%  17.6  
 Very high 55% 39%  10  
Close Modal

or Create an Account

Close Modal
Close Modal